Medication adherence

Psychiatric Annals

Volumn 38, Issue 5, 2008, Pages 323-326

  Howland, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 46749146603     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/00485713-20080501-05     Document Type: Article

References (34)

1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-497.
2. Bylerly MJ, Thompson A, Carmody T, et al. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatr Serv. 2007;58(6):844-847.
3. Koplan C, Charuvastra A, Compton MT, et al. Prevention psychiatry. Psychiatric Annals. 2007;37(5):319-328.
4. Baune BT, Adrian I, Jacobi F. Medical disorders affect health outcome and general functioning depending on comorbid major depression in the general population. J Psychosom Res. 2007;62(2):109-118.
5. Rivelli S, Jiang W. Depression and ischemic heart disease: What have we learned from clinical trials? Curr Opin Cardiol. 2007;22(4):286-29i.
6. Carnethon MR, Biggs ML, Barzilay JI, et al. Longitudinal association between depressive symptoms and incident type 2 diabetes mellitus in older adults: The cardiovascular health study. Arch Internal Med. 2007;167(8):802-807.
7. Diem SJ, Blackwell TL, Stone KL, et al. Depressive symptoms and rates of bone loss at the hip in older women. J Am Geriatr Soc. 2007;55(6):824-831.
8. Kilbourne AM, Reynolds CF, Good CB, Sereika SM, Justice AC, Fine MJ, How does depression influence diabetes medication adherence in older patients? Am J Geriatr Psychiatry. 2005;13(3):202-210.
9. Spernak SM, Moore PJ, Hamm LF. Depression, constructive thinking, and patient satisfaction in cardiac treatment adherence. Psychol Health Med. 2007;12(2): 172-189.
10. Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann KA, Rudick RA. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol. l997;54(5):531-533.
11. Safren SA, Hendricksen ES, Mayer KH, Mimiaga MJ, Pickard R, Otto MW. Cognitive-behavioral therapy for HIV medication adherence and depression. Cognitive and Behavioral Practice. 2004;11:415-424.
12. Knol MJ, Twisk JW, Beekman AT, Heine RJ, Snoek FJ, Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus: a metaanalysis. Diabetologia. 2006;49(5):837-845.
13. Gold DT, Solimeo S. Osteoporosis and depression: A historical perspective. Curr Osteoporos Rep.2006;4(4):134-139.
14. Ilias I, Alesci S, Gold PW, Chrousos GP. Depression and osteoporosis in men: association or casual link? Hormones (Athens). 2006;5(1):9-16.
15. O' Keane V, Marsh MS. Depression during pregnancy. BMJ. 2007;334(7601): 1003-1005.
16. Wisner KL, Zarin DA, Holmboe ES, et al. Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry. 2000; 157(12): 1933-1940.
17. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biological Psychiatry. 2006;59( 12): 1116-1127.
18. Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatrie disorders. Arch Gen Psychiatry. 2000;57(10):925-935.
19. Wenk GL, Parsons CG, Danysz W. Potential role of N-methyl-D-aspartate receptors as executors of neurodegeneration resulting from diverse insults: Focus on memantine. Behav Pharmacol. 2006;17(5-6):411-424.
20. Heine VM, Maslam S, Zareno J, Joëls M, Lucassen PJ. Suppressed proliferation and apoptotic changes in the rat dentate gyrus after acute and chronic stress are reversible. Eur J Neurosci. 2004;19(1):131-144.
21. Einat H, Manji HK. Cellular plasticity cascades: Genes-to-behavior pathways in animal models of bipolar disorder. Biol Psychiatry. 2006;59(12):1160-1171.
22. Toro CT, Deakin JFW. Adult neurogenesis and schizophrenia: A window on abnormal early brain development? Schizophr Res. 2007;90(1-3):1-14.
23. Gray NA, Zhou R, Du J, Moore GJ, Manji HK. The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatrie disorders. J Clin Psychiatry. 2003:64(Suppl5):3-17.
24. Cooper D, Moisan J, Grégoire JP. Adherence to atypical antipsychotic treatment among newly treated patients: A population-based study in schizophrenia. J Clin Psychiatry. 2007;68(6):818-825.
25. Cotrell V, Wild K, Bader T. Medication management and adherence among cognitively impaired older adults. J Gerontol Soc Work. 2006;47(3-4):31-46.
26. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Patient adherence in the treatment of depression. Br J Psychiatry. 2002;180:104-109.
27. Sajatovic M, Valenstein M, Blow F, Ganoczy D, Ignacio R. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr Serv. 2007;58(6):855-863.
28. Agostini JV. Measuring drug burden: A step forward. Arch Intern Med. 2007;167(8):753-754.
29. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: Associations with medication and medical utilization and spending and health. JAMA. 2007;298(1):61-69.
30. Byrne N, Regan C, Livingston G. Adherence to treatment in mood disorders. Curr Opin Psychiatry. 2006;19(1):44-49.
31. Helbling J, Ajdacic-Gross V, Lauber C, Weyermann R, Burns T, Rossler W. Attitudes to antipsychotic drugs and their side effects: A comparison between general practitioners and the general population. BMC Psychiatry. 2006:6,42.
32. Hunot VM, Home R, Leese MN, Churchill RC. A cohort study of adherence to antidepressants in primary care: The influence of antidepressant concerns and treatment preferences. Prim Care Companion J Clin Psychiatry. 2007;9(2):91-99.
33. Donohue JM, Berndt ER, Rosenthal M, Epstein AM, Frank RG. Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Medical Care. 2004;42(12): 1176-1185.
34. Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry. 2007;164(6):884-891.